The COVID-19 pandemic: model-based evaluation of non-pharmaceutical interventions and prognoses

被引:0
|
作者
Alex De Visscher
机构
[1] Concordia University,Department of Chemical and Materials Engineering, Gina Cody School of Engineering and Computer Science
来源
Nonlinear Dynamics | 2020年 / 101卷
关键词
SARS-CoV-2; Herd immunity; Social distancing; Doubling time; Case mortality rate;
D O I
暂无
中图分类号
学科分类号
摘要
An epidemiological model for COVID-19 was developed and implemented in MATLAB/GNU Octave for use by public health practitioners, policy makers, and the general public. The model distinguishes four stages in the disease: infected, sick, seriously sick, and better. The model was preliminarily parameterized based on observations of the spread of the disease. The model assumes a case mortality rate of 1.5%. Preliminary simulations with the model indicate that concepts such as “herd immunity” and containment (“flattening the curve”) are highly misleading in the context of this virus. Public policies based on these concepts are inadequate to protect the population. Only reducing the R0 of the virus below 1 is an effective strategy for maintaining the death burden of COVID-19 within the normal range of seasonal flu. The model is illustrated with the cases of Italy, France, and Iran and is able to describe the number of deaths as a function of time in all these cases although future projections tend to slightly overestimate the number of deaths when the analysis is made early on. The model can also be used to describe reopenings of the economy after a lockdown. The case mortality rate is still prone to large uncertainty, but modeling combined with an investigation of blood donations in The Netherlands imposes a lower limit of 1%.
引用
收藏
页码:1871 / 1887
页数:16
相关论文
共 50 条
  • [1] The COVID-19 pandemic: model-based evaluation of non-pharmaceutical interventions and prognoses
    De Visscher, Alex
    [J]. NONLINEAR DYNAMICS, 2020, 101 (03) : 1871 - 1887
  • [2] Pharmaceutical and non-pharmaceutical interventions for controlling the COVID-19 pandemic
    Molla, Jeta
    Farhang-Sardroodi, Suzan
    Moyles, Iain R.
    Heffernan, Jane M.
    [J]. ROYAL SOCIETY OPEN SCIENCE, 2023, 10 (12):
  • [3] Optimal Control of the COVID-19 Pandemic with Non-pharmaceutical Interventions
    Perkins, T. Alex
    Espana, Guido
    [J]. BULLETIN OF MATHEMATICAL BIOLOGY, 2020, 82 (09)
  • [4] Optimal Control of the COVID-19 Pandemic with Non-pharmaceutical Interventions
    T. Alex Perkins
    Guido España
    [J]. Bulletin of Mathematical Biology, 2020, 82
  • [5] Non-pharmaceutical interventions during the COVID-19 pandemic: A review
    Perra, Nicola
    [J]. PHYSICS REPORTS-REVIEW SECTION OF PHYSICS LETTERS, 2021, 913 : 1 - 52
  • [6] Analysis of non-pharmaceutical interventions impacts on COVID-19 pandemic in Iran
    Saadatmand, Sara
    Salimifard, Khodakaram
    Mohammadi, Reza
    [J]. NONLINEAR DYNAMICS, 2022, 109 (01) : 225 - 238
  • [7] Analysis of non-pharmaceutical interventions impacts on COVID-19 pandemic in Iran
    Sara Saadatmand
    Khodakaram Salimifard
    Reza Mohammadi
    [J]. Nonlinear Dynamics, 2022, 109 : 225 - 238
  • [8] Modeling non-pharmaceutical interventions in the COVID-19 pandemic with survey-based simulations
    Kaffai, Marius
    Heiberger, Raphael H.
    [J]. PLOS ONE, 2021, 16 (10):
  • [9] Evaluation on different non-pharmaceutical interventions during COVID-19 pandemic: An analysis of 139 countries
    Wong, Martin C. S.
    Huang, Junjie
    Teoh, Jeremy
    Wong, Sunny H.
    [J]. JOURNAL OF INFECTION, 2020, 81 (03) : E70 - E71
  • [10] Monitoring non-pharmaceutical public health interventions during the COVID-19 pandemic
    Shen, Yannan
    Powell, Guido
    Ganser, Iris
    Zheng, Qulu
    Grundy, Chris
    Okhmatovskaia, Anya
    Buckeridge, David L.
    [J]. SCIENTIFIC DATA, 2021, 8 (01)